Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ord Shs V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Post by TallerCraigon Jan 04, 2018 8:05pm
216 Views
Post# 27285619

Tall of the Tape - FMV of Net Assets 1.02/share

Tall of the Tape - FMV of Net Assets 1.02/shareJust a quick reminder....

On 2018 Numbers of 225M Rev and 26.5M EBITDA

- 1.5x EBITDA

- 0.67 BV/ share (1.02/share adjust for FMV of PPE)

- net/debt to EBITDA under 2.5x

- anlayst PT over 1.00/share

- Gross margin expansion could double in 2018

- Still recovery for 10-20% upside in pricing

- Reduction in low margin subcontract use

- Introduction of at well site service offering

- Consolidation will heat up with recovery in space

- WTI >60 w Rig count strong

- Tax loss selling over




Using only a 4x EBITDA multiple on 2018 numbers gets you to 1.80/share or still a triple...


If sentiment ever turns, look out!



<< Previous
Bullboard Posts
Next >>